Cmed, an innovative full service CRO and developer of smart e-clinical data capture and management technologies, announced today the launch of its new-look website, www.cmedresearch.com.
Featuring a clean, modern design with improved functionality and navigation, the new site provides quick and easy access to information about Cmed’s key strengths and experience. It is accessible through a wider range of web browsers and devices, including mobiles and tablets, and has been designed to meet all relevant accessibility standards.
The company has also adopted a new “Clear Advantage” tagline which will be used across a range of brand materials, including the new website, to better communicate the benefits of working with Cmed.
“The old website was becoming a little dated and no longer fully reflected our developing business, including our core strengths in areas like complex trials, oncology and rare diseases, the experience we have gained in working with small biopharma in drug development design and conducting their trials, and of course at the other end of the spectrum our success in long term Biometric strategic relationships with big pharmas” said Dr. David Connelly, Cmed’s CEO. “The new site presents our services, strengths and team in a clearer, more innovative and coherent way, mirroring the Cmed culture and vision”.
All company information will now be available from the one single site. Visitors to the old www.cmedgroup.com and www.cmedtechnology.com websites will automatically be redirected to www.cmedresearch.com. The new site also features a Careers section, where potential candidates can view open positions within the company’s UK, US and Romanian offices.
For further information about Cmed, visit the new website www.cmedresearch.com.
- ends -
About Cmed
Cmed is an innovative full service CRO and a software developer of smart e-clinical data capture and management technologies. Cmed was established in 2000 with the vision to conduct clinical trials better than anyone else, thus saving and helping lives. Cmed has a focus on bringing innovation to the design and conduct of clinical trials, including in the areas of clinical data capture, data management, monitoring. Cmed has two divisions: Cmed Clinical Services and Cmed Technology.
Cmed Clinical Services is a global CRO providing services to the Biopharma industry worldwide. Cmed works with clients to not only deliver the clinical trial services effectively, and with quality, passion, teamwork and superior customer service, but also, especially for full service projects, by understanding the clients commercial and business objectives. Cmed then leverages its in-depth expertise to ensure the development program and/or clinical trial is well designed and conducted as efficiently and as cost effectively as possible. Cmed has particular expertise in the design and conduct of complex, oncology and rare disease trials and the provision of Biometric functional services.
Cmed Technology designed and developed Timaeus: a unique single platform for electronic trial design, paper & electronic data capture, monitoring, coding, data management and reporting. Using distributed cloud computing and mobile technologies, Timaeus has been deployed in over 400 clinical trials and has successfully passed multiple audits. The unique Timaeus design provides a number of benefits to our clients including rapid database build (weeks not months), mid-trial updates without down-time and non-reliance on the internet. These benefits lead to many advantages including the removal of EDC build from study start-up, no restriction on investigator site selection, no negative impact on recruitment timelines due to design changes, and elevated investigator motivation.
